Q32 Bio Inc Com (FIXX)

Q32 Bio Inc Com (FIXX)
- Cap: $54M
- View FIXX Profile
- View Questions on FIXX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Q32 Bio Inc Com (FIXX)
- Cap: $54M
- View FIXX Profile
- View Questions on FIXX

Q: FIXX is doing a secondary offering at $22.50/s, down 28% from its trading price just three days ago. Is this just the effects of diluting the existing market cap with 6.4M more shares? Rather than, say, investors supposing that more working capital is a bad idea.

Read Answer Asked by John on April 11, 2019